Featuring premier experts from Jordi Labs, an RQM+ Company.
Live! #84 panel | Recorded 21 November 2024
Available on demand.
As significant changes to ISO 10993-1 loom on the horizon, manufacturers across MedTech are seeking clarity on what's coming and how to prepare. Join our expert panel for an essential discussion on these upcoming revisions to ISO 10993-1 and their far-reaching implications for biological evaluation processes.
Our panel will provide actionable insights into:
Who Should Attend: This session is essential for regulatory affairs professionals, quality managers, and R&D teams involved in medical device development and biological safety assessment. Whether you're preparing for upcoming changes or seeking to optimize your current processes, this discussion will provide actionable insights for maintaining compliance and efficiency.
Panelists:
Moderator:
Register now to gain critical insights into these industry-shifting changes and ensure your organization is prepared for what the transcript reveals to be "one of the major changes in the standard" - the requirement to apply device risk management to biological evaluation.
Certificate of Participation available upon request for live attendees.
©2024 RQM+ All Rights Reserved | Cookies Policy | Privacy Statement